Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lurasidone vs risperidone in schizophrenia
CTR20160166Phase 3Terminated
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lurasidone in schizophrenia, sponsored by Chia Tai-Tianqing Pharmaceutical Group. Started Apr 2016; status: terminated.
02
Drugs
lurasidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on CTR20160166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160166.